Brendan O'Grady is Amwell's new chief commercial and growth officer, the company announced July 22.
Mr. O'Grady has served on Amwell's board since 2015. As chief commercial and growth officer, he will oversee strategic growth initiatives and lead business development, sales, marketing and account management teams at the telehealth company.
Prior to joining Amwell, Mr. O'Grady served as president and CEO of Teva Pharmaceuticals' North American operations, where he was responsible for managing and scaling productivity and profits.